Medical Technology Commercialization Strategy
The Commercialization Strategy serves as a framework and actionable plan to achieve the highest return on in investment (ROI) for your medical innovation.
Strategy Inc. is experienced in helping innovators bring their medical technologies to US markets, combining understanding of clinical landscapes and healthcare facility purchasing practices with strategic thinking.
Investors and executive management alike require confirmation of market opportunity, projected adoption, competitive landscape and risk analysis for defensible revenue projections. Essential diligence collected from both primary and robust secondary data will construct the blueprint for a strong foundation. Understanding the current and anticipated future markets where your medical technology will compete, target market options, and anticipated developments and risk hurdles ensures comprehension and confidence of the innovation’s adopted trajectory. This is an area where the best practice due diligence yield cost effective information that is the basis for vetted decision making.
For new market entrants, either from emerging technologies or entities outside the US seeking US commercialization, Strategy Inc. can help develop identify, prioritize and target key market segments with a go-to-market strategy. A multi-stage process, the go-to-market strategy is built on first identifying necessary market diligence to support strategic decision making in the commercialization process, followed by framing the sales and marketing plans. Experience has shown that a strategy built on focused diligence with advisement supported by dedicated research has the highest potential for success.
Diligence components of a go-to-market strategy include, but are not limited to:
- Voice of the Customer: Clinical Adoption Analysis
- Prioritization of Key Market Segments
- Competitive Landscape and Positioning Strategy
- Comparative Pricing Analysis
- Risk Assessment and Mitigation Mapping
At Strategy Inc. experience has confirmed that many of our service offerings are paramount to developing a framework for successful commercialization launch strategy.